Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection/Experiment 8/Signature 2
From BugSigDB
< Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection | Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection/Experiment 8
Source: Figure 5B
Description: Violin plots illustrating differences in gut microbiota abundance at the phylum level before and after BL21 intervention at different time points. Different letters indicate statistically significant differences between groups.
Abundance in Group 1: decreased abundance in Polycystic Ovary Syndrome (PCOS_End) group
| NCBI | Quality Control | Links |
|---|---|---|
| Campylobacterota | ||
| Bacillota |
Revision editor(s): Victoria
